[1] Kullberg B J,Oude Lashot A M. Epidemiology of Opportunistic Invasive Mycoses[J]. Eur J Med Res ,2002,7(5):183-191. [2] Patterson T F. Advances and Challenges in Management of Invasive Mycoses[J]. Lancet ,2005,366:1013-1025. [3] Caston-Osorio J J,Rivero A,Torre-Cisneros J. Epidemiology of Invasive Fungal Infection[J]. Int J Antimicrob Agents ,2008,32:S103-S109. [4] Aronld L D,Sergio S. Microbial Drug Discovery:80 Years of Progress[J]. J Antibiot ,2009,62:5-16. [5] Robert A,Fromtling. Overview of Medically Important Antifungal Azole Derivatives[J]. Clin Microbiol Rev ,1988,1(2):187-217. [6] Gallis H A,Drew R H,Pickard W W. Amphotericin B:30 Years of Clinical Experience[J]. Rev Infect Dis ,1990,12:308-329. [7] Arikan S,Rex J H. Nystatin LF(Aronex/Abbott)[J]. Curr Opin Invest Drugs ,2001,2:488-495. [8] Grover N D. Echinocandins:A Ray of Hope in Antifungal Drug Therapy[J]. Indian J Pharmacol ,2010,42(1):9-11. [9] Birnbaum J E. Pharmacology of the Allylamines[J]. J Am Acad Dermatol ,1990,23:782-785. [10] Sheng C,Zhang W,Ji H, et al . Structure-based Optimization of Azole Antifungal Agents by CoMFA,CoMSIA, and Molecular Docking[J]. J Med Chem ,2006,49:2512-2525. [11] Feng Z X,Zhang W N,Zhou Y J, et al . Synthesis and Antifungal Activities of 1-[2-(N-methyl-N-sub-stituted-benzyl) amino-2-(2,4-dichlorophenyl)ethyl]-1 H -1,2,4-triazoles[J]. J Chin Pharm Sci ,2000,9(4):174-178. [12] Meerpoel L,Backx L J,Van der Veken L J, et al . Synthesis and in Vitro and in Vivo Structure-activity Relationships of Novel Antifungal Triazoles for Dermatology[J]. J Med Chem ,2005,48(6):2184-2193. [13] SHENG Chunquan,ZHU Jie,ZHANG Wannian, et al . Synthesis and Antifungal Activity of N-[2-(2,4-difluoro-phenyl)-2-hydroxyl-3-(1 H -1,2,4-triazolyl)]-acetone[J]. Chinese J Pharm ,2006,41(6):469-471(in Chinese). 盛春泉,朱杰,张万年,等. N -[2-(2,4-二氟苯基)-2-羟基-3-(1 H -1,2,4-三唑)]-酮的合成和抗真菌活性[J]. 中国药学杂志,2006,41(6):469-471. [14] Kagoshima Y,Konosu T. Substituent Effect of Fluorine Atoms in the 2,4-Difluorophyenyl Group on Antifungal Activity of CS-758[J]. J Flour Chem ,2006,127:643-645. [15] Wang W,Sheng C,Che X, et al . Design, Synthesis, and Anti-fungal Activity of Novel Conformationally Restricted Triazole Derivatives[J]. Arch Pharm (Weinheim),2009,342(12):732-739. [16] Wang W,Wang S,Liu Y, et al . Novel Conformationally Restricted Triazole Derivatives with Potent Antifungal Activity[J]. Eur J Med Chem ,2010,45(12):6020-6026. [17] Sheng C,Che X,Wang W, et al . Structure-Based Design, Synthesis, and Antifungal Activity of New Triazole Derivatives[J]. Chem Biol Drug Des ,2011,78(2):309-313. [18] CHEN Yong,ZHANG Hao,MA Yingying, et al . Synthesis of Novel Triazole and Imidazole Derivative Containing Biphenyl[J]. Chem Res Appl ,2011,23(3):302-304(in Chinese). 陈勇,张浩,马莹莹,等. 含联苯基的三氮唑和咪唑衍生物的合成[J]. 化学研究与应用,2011,23(3):302-304. [19] CHEN Yong,GAO Junfei,ZHANG Guilin,Synthesis of 1-[2', 4'-Difluroro-(1,1'-biphenyl-4-yl-phenyl-methyl)-1,2,4-trazole[J]. J Huazhong Normal Univ (Nat Sci),2010,44(2):240-242(in Chinese). 陈勇,高俊飞,张贵林. 1-[2',4'-二氟(1,1'-联苯)-4-基苯基甲基]-1,2,4-三氮唑的合成与表征[J]. 华中师范大学学报(自然科学版),2010,44(2):240-242. [20] LEI Xiaoping,XU Ping. Medicinal Chemistry[M]. Beijing:Higher Education Press,2010:586-587(in Chinese). 雷小平,徐萍. 药物化学[M]. 北京:高等教育出版社,2010:586-587. |